![](https://cme.smhs.gwu.edu/sites/default/files/styles/course_image/public/course/2022-11/iStock-1293432105.jpg?itok=EIj2Zs1p)
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers
This module will introduce learners to the American Society of Clinical Oncology (ASCO) guideline summary on managing chemotherapy-induced peripheral neuropathy in survivors of adult cancers.
Learning Objectives
After completing this self-paced free training, you will be able to:
• Identify chemotherapy agents associated with neuropathy in adult patients with cancer and associated symptoms
• Describe strategies to prevent chemotherapy-induced peripheral neuropathy
• Describe strategies to treat chemotherapy-induced peripheral neuropathy that develops during or after neurotoxic chemotherapy
Guido Cavaletti, MD
University of Milano-Bicocca
School of Medicine and Surgery
Available Credit
- 0.25 Completion